September 16, 2014 11:33 AM ET

Pharmaceuticals

Company Overview of AmpliMed Corporation

Company Overview

AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.

4380 North Campbell Avenue

Suite 205

Tucson, AZ 85718

United States

Founded in 1989

Phone:

520-529-1000

Fax:

520-529-3001

Key Executives for AmpliMed Corporation

Chief Executive Officer
Chief Financial Officer & Vice President
Director of Finance and Administration
Age: 56
Executive Vice President
Director of Intellectual Property and Project Planning
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
OncoSource Rx, LLC United States
AMBI Pharmaceuticals, Inc. United States
MedPodium Health Products, Inc. United States
Waterstone Pharmaceuticals, Inc. United States
Xenacare Holdings Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AmpliMed Corporation, please visit www.amplimed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.